BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16902904)

  • 1. [Lipohypertrophy].
    Müssig K; Gallwitz B
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1807-8. PubMed ID: 16902904
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical signs for the general dental practitioner. Case 74. Lipohypertrophy.
    Bain S
    Dent Update; 2010 May; 37(4):268. PubMed ID: 20527502
    [No Abstract]   [Full Text] [Related]  

  • 3. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.
    Wallymahmed ME; Littler P; Clegg C; Haqqani MT; Macfarlane IA
    Postgrad Med J; 2004 Dec; 80(950):732-3. PubMed ID: 15579616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Despite inpatient education: knowledge gaps in a diabetic patient].
    Harsch IA
    MMW Fortschr Med; 2009 Mar; 151(13):6. PubMed ID: 19504806
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipohypertrophy--a complication of insulin injections.
    de Villiers FP
    S Afr Med J; 2005 Nov; 95(11):858-9. PubMed ID: 16344882
    [No Abstract]   [Full Text] [Related]  

  • 6. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
    Tavare AN; Doolittle HJ; Baburaj R
    Diabet Med; 2011 Apr; 28(4):500-3. PubMed ID: 21392071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.
    Endo JO; Röcken C; Lamb S; Harris RM; Bowen AR
    J Am Acad Dermatol; 2010 Dec; 63(6):e113-4. PubMed ID: 21093656
    [No Abstract]   [Full Text] [Related]  

  • 8. Switching from an oral regimen to insulin in diabetes.
    Perry M
    Community Nurse; 2000 May; 6(4):27-8. PubMed ID: 12778520
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin treatment in type 2 diabetes].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):919-20. PubMed ID: 16554885
    [No Abstract]   [Full Text] [Related]  

  • 11. Overcoming barriers to insulin replacement.
    Kuritzky L
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract]   [Full Text] [Related]  

  • 12. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

  • 13. Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate.
    D'Souza A; Theis JD; Vrana JA; Buadi F; Dispenzieri A; Dogan A
    Am J Hematol; 2012 Nov; 87(11):E131-2. PubMed ID: 23044893
    [No Abstract]   [Full Text] [Related]  

  • 14. Arguments against the use of inhaled insulin.
    Hirsch IB
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S111-4. PubMed ID: 17563299
    [No Abstract]   [Full Text] [Related]  

  • 15. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
    Rave K; Heise T; Pfützner A; Boss AH
    Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744
    [No Abstract]   [Full Text] [Related]  

  • 16. Distant site lipoatrophy: a rare complication of subcutaneous insulin therapy.
    Chakraborty PP; Biswas SN
    Postgrad Med J; 2016 Jan; 92(1083):57-8. PubMed ID: 26561591
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.
    Vardar B; Kizilci S
    Diabetes Res Clin Pract; 2007 Aug; 77(2):231-6. PubMed ID: 17303282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-Mediated Lipohypertrophy.
    Verma R
    N Engl J Med; 2017 Aug; 377(6):573. PubMed ID: 28792866
    [No Abstract]   [Full Text] [Related]  

  • 20. New injection recommendations for patients with diabetes.
    Frid A; Hirsch L; Gaspar R; Hicks D; Kreugel G; Liersch J; Letondeur C; Sauvanet JP; Tubiana-Rufi N; Strauss K;
    Diabetes Metab; 2010 Sep; 36 Suppl 2():S3-18. PubMed ID: 20933208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.